Your browser doesn't support javascript.
loading
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age.
Marshall, Gary S; Pelton, Stephen I; Robertson, Corwin A; Oster, Philipp.
Affiliation
  • Marshall GS; Division of Pediatric Infectious Diseases, Norton Children's and University of Louisville School of Medicine, Louisville, KY, USA.
  • Pelton SI; Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.
  • Robertson CA; US Medical Affairs, Sanofi, Discovery Drive, Swiftwater, PA, USA.
  • Oster P; Global Medical Affairs, Sanofi, Lyon, France.
Hum Vaccin Immunother ; 18(6): 2099142, 2022 Nov 30.
Article in En | MEDLINE | ID: mdl-35947774
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Meningococcal Infections / Neisseria meningitidis Limits: Child / Humans / Infant Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Meningococcal Infections / Neisseria meningitidis Limits: Child / Humans / Infant Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos